Axxess Pharma, Inc. Reports Ontario and Vancouver Manufacturing Locations Now Operating in Full Force Following Successful 3 Yea
08 July 2010 - 10:00PM
Marketwired
Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company
specializing in the marketing and distribution of both prescription
and non-prescription medical products is pleased to announce their
Ontario and Vancouver manufacturing locations and facilities are
now operating in full force following the successful 3 year annual
inspection by Health Canada.
This successful inspection comes following Axxess Pharma's most
recent Letter of Intent (LOI) to acquire a Canada-based
pharmaceutical manufacturer. This location generates over $2
million in annual revenues to Axxess Pharma, Inc.'s financials.
The Company's facility is roughly 22,000 square feet and
manufactures pharmaceuticals, neutroceuticals and dermatologicals.
Axxess Pharma will continue the distribution of its own line of
pharmaceuticals from its Markham location.
"We are very excited to receive approval from Health Canada. Our
facilities are now in place to process and manufacture all orders
worldwide. In recent months we have signed exclusive license
agreements in Latin America, Africa, Middle East and Canada with
non-exclusive sales in the United States and various other
countries," stated Gerald Sequeira, President/CEO. "This is one
more sign that we are focused on continuing to expand our
operations across Canada and gain market share," stated Gerald
Sequeira, President/CEO.
For more information, please contact Investor Relations at (973)
351-3868 or visit the company website directly:
http://www.axxesspharma.com.
About Axxess Pharma, Inc.:
Axxess Pharma, Inc. is a specialty pharmaceutical company that
focuses on the marketing of dermatological, therapeutic
nutritionals, pain management and diagnostic products in Canada and
abroad since 1997. Axxess owns 22 established pharmaceutical
prescription products that have proven sales in Canada and
internationally. The company has an experienced management team and
field sales force to market products nationally to hospitals and
retail pharmacies as well as specialized practice areas including
Dermatology and Nephrology, Neurology and Urology.
Safe Harbor
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Taylor Capitol, Inc. Investor Relations Stephen Taylor
973-351-3868 Email Contact
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024